tirzepatide weight loss clinical trial shows 47% greater vs. Wegovy Phentermine vs tirzepatide: the complete
Description
This retrospective cohort study identified patients who received GLP-1 RA treatment and matched them with non-GLP-1 RA users
It copies the effects of two natural hormones that control appetite and digestion GLP-1 and GIP
It should be emphasised that clinically significant hypoglycaemia is uncommon with tirzepatide monotherapy but is more likely when combined with insulin or sulfonylureas, as noted in the MHRA SmPC
When to consider switching back Give semaglutide at least 16 weeks at your target dose before evaluating whether the switch was successful
The pen may be kept at room temperature for a limited period as specified in the product information
doi: 10.1136/bmjdrc-2022-003206
